Lysophosphatidic acid: Chemical signature of neuropathic pain

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 61-73

  Ueda, Hiroshi ^a   Matsunaga, Hayato ^a   Olaposi, Omotuyi I ^a   Nagai, Jun ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Axonal sprouting; Calpain; Demyelination; Lysophosphatidic acid; Neuropathic pain; Schwann cell

Indexed keywords

AUTOTAXIN; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALPAIN 1; CALPAIN 2; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 2; GLUTAMIC ACID; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; LIM KINASE 1; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELIN BASIC PROTEIN; MYELIN PROTEIN; N METHYL DEXTRO ASPARTIC ACID; NEU DIFFERENTIATION FACTOR; NEUROKININ 1 RECEPTOR; NOGO 66 RECEPTOR; RHO KINASE; S6 KINASE; SUBSTANCE P; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SOX10; VANILLOID RECEPTOR 1;

ACTION POTENTIAL; ALLODYNIA; CYTOSKELETON; DEMYELINATION; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HYPERALGESIA; INTRACELLULAR SIGNALING; LIGAND BINDING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROGLIA; MICROTUBULE ASSEMBLY; NERVE FIBER GROWTH; NEUROPATHIC PAIN; PAIN THRESHOLD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SCHWANN CELL; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; DEMYELINATING DISEASES; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; NEURALGIA; NEURONS; SIGNAL TRANSDUCTION;

MUS;

EID: 84868566365     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.08.014     Document Type: Review

References (132)

1. C.J. Woolf, and Q. Ma Nociceptors - noxious stimulus detectors Neuron 55 2007 353 364
2. H.L. Fields, A.I. Basbaum, and M.M. Heinricher Central nervous system mechanisms of pain modulation Wall and Melzack's Textbook of Pain 2006 125 142
3. A.V. Apkarian, M.N. Baliki, and P.Y. Geha Towards a theory of chronic pain Prog. Neurobiol. 87 2009 81 97
4. M. Costigan, J. Scholz, and C.J. Woolf Neuropathic pain: a maladaptive response of the nervous system to damage Annu. Rev. Neurosci. 32 2009 1 32
5. N.E. Saadé, and S.J. Jabbur Nociceptive behavior in animal models for peripheral neuropathy: spinal and supraspinal mechanisms Prog. Neurobiol. 86 2008 22 47
6. H. Ueda Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms Pharmacol. Ther. 109 2006 57 77
7. H. Ueda Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination Mol. Pain 4 2008 11
8. H. Ueda, and M. Ueda Lysophosphatidic acid as initiator of neuropathic pain - biosynthesis and demyelination J. Clin. Lipid. 6 2011 147 158
9. C. Toth, J. Lander, and S. Wiebe The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population Pain Med. 10 2009 918 929
10. Christian A. von Hehn, R. Baron, and Clifford J. Woolf Deconstructing the neuropathic pain phenotype to reveal neural mechanisms Neuron 73 2012 638 652
11. J.N. Campbell, and R.A. Meyer Mechanisms of neuropathic pain Neuron 52 2006 77 92
12. M. Matsumoto Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin J. Pharmacol. Exp. Ther. 318 2006 735 740
13. B.F. Jung, D. Herrmann, J. Griggs, A.L. Oaklander, and R.H. Dworkin Neuropathic pain associated with non-surgical treatment of breast cancer Pain 118 2005 10 14
14. S. Boogaard, M.W. Heymans, J. Patijn, H.C. de Vet, C.G. Faber, M.L. Peters, S.A. Loer, W.W. Zuurmond, and R. Perez Predictors for persistent neuropathic pain-a Delphi survey Pain Physician 14 2011 559 568
15. H. Uchida, L. Ma, and H. Ueda Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain J. Neurosci. 30 2010 4806 4814
16. A. Doehring, G. Geisslinger, and J. Lotsch Epigenetics in pain and analgesia: an imminent research field Eur. J. Pain 15 2011 11 16
17. M. Inoue, M.H. Rashid, R. Fujita, J.J.A. Contos, J. Chun, and H. Ueda Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling Nat. Med. 10 2004 712 718
18. R. Fujita, N. Kiguchi, and H. Ueda LPA-mediated demyelination in ex vivo culture of dorsal root Neurochem. Int. 50 2007 351 355
19. J. Nagai, H. Uchida, Y. Matsushita, R. yano, M. Ueda, M. Niwa, J. Aoki, J. Chun, and H. Ueda Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine Mol. Pain 6 2010 78
20. W. Xie, H. Uchida, J. Nagai, M. Ueda, J. Chun, and H. Ueda Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain J. Neurochem. 113 2010 1002 1011
21. D.K. Ahn, S.Y. Lee, S.R. Han, J.S. Ju, G.Y. Yang, M.K. Lee, D.H. Youn, and Y.C. Bae Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats Pain 146 2009 114 120
22. H. Uchida, M. Matsumoto, and H. Ueda Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia Neurochem. Int. 54 2009 215 221
23. H. Shindou, and T. Shimizu Acyl-CoA: lysophospholipid acyltransferases J. Biol. Chem. 284 2008 1 5
24. a.D.E.V.H. Van den Bosch Phospholipid biosynthesis: current status of the Kennedy and related pathways Biochim. Biophys. Acta 1997 1 256
25. R. Coleman Enzymes of triacylglycerol synthesis and their regulation Prog. Lipid Res. 43 2004 134 176
26. G.B. Mills, and W.H. Moolenaar The emerging role of lysophosphatidic acid in cancer Nat. Rev. Cancer 3 2003 582 591
27. R. Rivera, and J. Chun Biological effects of lysophospholipids Rev. Physiol. Biochem. Pharmacol. 160 2008 25 46
28. N. Fukushima LPA in neural cell development J. Cell. Biochem. 92 2004 993 1003
29. K. Noguchi, D. Herr, T. Mutoh, and J. Chun Lysophosphatidic acid (LPA) and its receptors Curr. Opin. Pharmacol. 9 2009 15 23
30. M.A. Kingsbury, S.K. Rehen, X. Ye, and J. Chun Genetics and cell biology of lysophosphatidic acid receptor-mediated signaling during cortical neurogenesis J. Cell. Biochem. 92 2004 1004 1012
31. A. Nieto-Posadas, G. Picazo-Juarez, I. Llorente, A. Jara-Oseguera, S. Morales-Lazaro, D. Escalante-Alcalde, L.D. Islas, and T. Rosenbaum Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site Nat. Chem. Biol. 8 2012 78 85
32. K. Renback, M. Inoue, A. Yoshida, F. Nyberg, and H. Ueda Vzg-1/lysophosphatidic acid-receptor involved in peripheral pain transmission Brain Res. Mol. Brain Res. 75 2000 350 354
33. K. Renback, M. Inoue, and H. Ueda Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice Neurosci. Lett. 270 1999 59 61
34. M.E. Lin, R.R. Rivera, and J. Chun Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain J. Biol. Chem. 287 2012 17608 17617
35. 2 + entry and vascular tone in intact aorta Am. J. Physiol. Heart Circ. Physiol. 295 2008 H2466 H2474
36. N.K. Liu, Y.P. Zhang, W.L. Titsworth, X. Jiang, S. Han, P.H. Lu, C.B. Shields, and X.M. Xu A novel role of phospholipase A2 in mediating spinal cord secondary injury Ann. Neurol. 59 2006 606 619
37. H. Su, G. McClarty, F. Dong, G.M. Hatch, Z.K. Pan, and G. Zhong Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids J. Biol. Chem. 279 2004 9409 9416
38. M. Inoue, L. Ma, J. Aoki, and H. Ueda Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain J. Neurochem. 107 2008 1556 1565
39. L. Ma, H. Uchida, J. Nagai, M. Inoue, J. Aoki, and H. Ueda Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain J. Pharmacol. Exp. Ther. 333 2010 540 546
40. L. Ma, J. Nagai, and H. Ueda Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain J. Neurochem. 115 2010 643 653
41. I. Bosch, K. Dunussi-Joannopoulos, R.L. Wu, S.T. Furlong, and J. Croop Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein Biochemistry 36 1997 5685 5694
42. M.J. Caterina, A. Leffler, A.B. Malmberg, W.J. Martin, J. Trafton, K.R. Petersen-Zeitz, M. Koltzenburg, A.I. Basbaum, and D. Julius Impaired nociception and pain sensation in mice lacking the capsaicin receptor Science 288 2000 306 313
43. M.F. Wyatt, S. Ding, B.K. Stein, A.G. Brenton, and R.H. Daniels Analysis of various organic and organometallic compounds using nanostructure-assisted laser desorption/ionization time-of-flight mass spectrometry (NALDI-TOFMS) J. Am. Soc. Mass Spectrom. 21 2010 1256 1259
44. E. Guénin, M. Lecouvey, and J. Hardouin Could a nano-assisted laser desorption/ionization target improve the study of small organic molecules by laser desorption/ionization time-of-flight mass spectrometry? Rapid Commun. Mass Spectrom. 23 2009 1395 1400
45. J. Nagai, and H. Ueda Pre-emptive morphine treatment abolishes nerve injury-induced lysophospholipid synthesis in mass spectrometrical analysis J. Neurochem. 118 2011 256 265
46. L.A. Dykstra, B.D. Fischer, R.E. Balter, F.E. Henry, K.T. Schmidt, and L.L. Miller Opioid antinociception, tolerance and dependence: interactions with the N-methyl-d-aspartate system in mice Behav. Pharmacol. 22 2011 540 547
47. C. Ghelardini, N. Galeotti, E. Vivoli, M. Norcini, W. Zhu, G.B. Stefano, M. Guarna, and E. Bianchi Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception J. Neurochem. 105 2008 91 100
48. 2 + signaling and Rho J. Neurochem. 66 1996 537 548
49. U. Funfschilling, L.M. Supplie, D. Mahad, S. Boretius, A.S. Saab, J. Edgar, B.G. Brinkmann, C.M. Kassmann, I.D. Tzvetanova, W. Mobius, F. Diaz, D. Meijer, U. Suter, B. Hamprecht, M.W. Sereda, C.T. Moraes, J. Frahm, S. Goebbels, and K.A. Nave Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity Nature 485 2012 517 521
50. J.A. Pereira, F. Lebrun-Julien, and U. Suter Molecular mechanisms regulating myelination in the peripheral nervous system Trends Neurosci. 35 2012 123 134
51. J. Svaren, and D. Meijer The molecular machinery of myelin gene transcription in Schwann cells Glia 56 2008 1541 1551
52. N.B. Jagalur, M. Ghazvini, W. Mandemakers, S. Driegen, A. Maas, E.A. Jones, M. Jaegle, F. Grosveld, J. Svaren, and D. Meijer Functional dissection of the Oct6 Schwann cell enhancer reveals an essential role for dimeric Sox10 binding J. Neurosci. 31 2011 8585 8594
53. D.L. Sherman, M. Krols, L.M. Wu, M. Grove, K.A. Nave, Y.G. Gangloff, and P.J. Brophy Arrest of myelination and reduced axon growth when Schwann cells lack mTOR J. Neurosci. 32 2012 1817 1825
54. T.R. Fenton, J. Gwalter, J. Ericsson, and I.T. Gout Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo Int. J. Biochem. Cell Biol. 42 2010 359 366
55. M. Frodin, and S. Gammeltoft Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction Mol. Cell. Endocrinol. 151 1999 65 77
56. J.Y. Lim, H. Kim, Y.H. Kim, S.W. Kim, P.W. Huh, K.H. Lee, S.S. Jeun, H.K. Rha, and J.K. Kang Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway Biochem. Biophys. Res. Commun. 302 2003 238 245
57. Y. Chen, H. Wang, S.O. Yoon, X. Xu, M.O. Hottiger, J. Svaren, K.A. Nave, H.A. Kim, E.N. Olson, and Q.R. Lu HDAC-mediated deacetylation of NF-kappaB is critical for Schwann cell myelination Nat. Neurosci. 14 2011 437 441
58. A. Dobretsova, J.W. Johnson, R.C. Jones, R.D. Edmondson, and P.A. Wight Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene J. Neurochem. 105 2008 1979 1995
59. S.W. Jang, and J. Svaren Induction of Myelin Protein Zero by Early Growth Response 2 through Upstream and Intragenic Elements J. Biol. Chem. 284 2009 20111 20120
60. E.A. Jones, C. Lopez-Anido, R. Srinivasan, C. Krueger, L.W. Chang, R. Nagarajan, and J. Svaren Regulation of the PMP22 gene through an intronic enhancer J. Neurosci. 31 2011 4242 4250
61. S.C. Kao, H. Wu, J. Xie, C.P. Chang, J.A. Ranish, I.A. Graef, and G.R. Crabtree Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation Science 323 2009 651 654
62. N.L. Banik, C.H. Chou, G.E. Deibler, H.C. Krutzch, and E.L. Hogan Peptide bond specificity of calpain: proteolysis of human myelin basic protein J. Neurosci. Res. 37 1994 489 496
63. D.C. Shields, W.R. Tyor, G.E. Deibler, and N.L. Banik Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study Brain Res. 784 1998 299 304
64. A.W. Smith, B.P. Doonan, W.R. Tyor, N. Abou-Fayssal, A. Haque, and N.L. Banik Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients J. Neuroimmunol. 232 2011 179 185
65. D.E. Goll, V.F. Thompson, H. Li, W. Wei, and J. Cong The calpain system Physiol. Rev. 83 2003 731 801
66. 2 +-dependent proteinases (mu-calpain and m-calpain) J. Biol. Chem. 264 1989 10096 10103
67. N. Yang, O. Higuchi, K. Ohashi, K. Nagata, A. Wada, K. Kangawa, E. Nishida, and K. Mizuno Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization Nature 393 1998 809 812
68. J.A. Weiner, N. Fukushima, J.J. Contos, S.S. Scherer, and J. Chun Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling J. Neurosci. 21 2001 7069 7078
69. C.L. Sayas, J. Avila, and F. Wandosell Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3 Biochim. Biophys. Acta 1582 2002 144 153
70. H. Muniyappa, and K.C. Das Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism Cell. Signal. 20 2008 675 683
71. K.C. Das, and H. Muniyappa c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1 Mol. Cell. Biochem. 337 2010 53 63
72. C. Aguilera, K. Nakagawa, R. Sancho, A. Chakraborty, B. Hendrich, and A. Behrens c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex Nature 469 2011 231 235
73. D.B. Parkinson, A. Bhaskaran, P. Arthur-Farraj, L.A. Noon, A. Woodhoo, A.C. Lloyd, M.L. Feltri, L. Wrabetz, A. Behrens, R. Mirsky, and K.R. Jessen c-Jun is a negative regulator of myelination J. Cell Biol. 181 2008 625 637
74. T. Sumi, K. Matsumoto, Y. Takai, and T. Nakamura Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2 J. Cell Biol. 147 1999 1519 1532
75. N. Le, R. Nagarajan, J.Y. Wang, T. Araki, R.E. Schmidt, and J. Milbrandt Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination Proc. Natl. Acad. Sci. U. S. A. 102 2005 2596 2601
76. L. Cotter, M. Ozcelik, C. Jacob, J.A. Pereira, V. Locher, R. Baumann, J.B. Relvas, U. Suter, and N. Tricaud Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination Science 328 2010 1415 1418
77. T. Sanchez PTEN as an effector in the signaling of antimigratory G protein-coupled receptor Proc. Natl. Acad. Sci. 102 2005 4312 4317
78. Z. Li, X. Dong, Z. Wang, W. Liu, N. Deng, Y. Ding, L. Tang, T. Hla, R. Zeng, L. Li, and D. Wu Regulation of PTEN by Rho small GTPases Nat. Cell Biol. 7 2005 399 404
79. J.A. Engelman, J. Luo, and L.C. Cantley The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism Nat. Rev. Genet. 7 2006 606 619
80. F. Llorens, V. Gil, and J.A. del Rio Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration FASEB J. 25 2011 463 475
81. C.L. McDonald, C. Bandtlow, and M. Reindl Targeting the Nogo receptor complex in diseases of the central nervous system Curr. Med. Chem. 18 2011 234 244
82. S. Wakatsuki, F. Saitoh, and T. Araki ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation Nat. Cell Biol. 13 2011 1415 1423
83. C. Dan, A. Kelly, O. Bernard, and A. Minden Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin J. Biol. Chem. 276 2001 32115 32121
84. N. Arimura, C. Menager, Y. Fukata, and K. Kaibuchi Role of CRMP-2 in neuronal polarity J. Neurobiol. 58 2004 34 47
85. L.C. Weaver, D.R. Marsh, D. Gris, A. Brown, and G.A. Dekaban Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention Prog. Brain Res. 152 2006 245 263
86. H.A. Lekan, S.M. Carlton, and R.E. Coggeshall Sprouting of A beta fibers into lamina II of the rat dorsal horn in peripheral neuropathy Neurosci. Lett. 208 1996 147 150
87. V. DesMarais, F. Macaluso, J. Condeelis, and M. Bailly Synergistic interaction between the Arp2/3 complex and cofilin drives stimulated lamellipod extension J. Cell Sci. 117 2004 3499 3510
88. N. Arimura, and K. Kaibuchi Neuronal polarity: from extracellular signals to intracellular mechanisms Nat. Rev. Neurosci. 8 2007 194 205
89. R.R. Ji, H. Baba, G.J. Brenner, and C.J. Woolf Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity Nat. Neurosci. 2 1999 1114 1119
90. L.B. Rosen, D.D. Ginty, M.J. Weber, and M.E. Greenberg Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras Neuron 12 1994 1207 1221
91. M. Matsumoto, W. Xie, L. Ma, and H. Ueda Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury Mol. Pain 4 2008 25
92. C.H. Kim, Y. Oh, J.M. Chung, and K. Chung The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation Brain Res. Mol. Brain Res. 95 2001 153 161
93. A. Tulleuda, B. Cokic, G. Callejo, B. Saiani, J. Serra, and X. Gasull TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury Mol. Pain 7 2011 30
94. 2 + channel EMBO J. 20 2001 2349 2356
95. S. Hatakeyama, M. Wakamori, M. Ino, N. Miyamoto, E. Takahashi, T. Yoshinaga, K. Sawada, K. Imoto, I. Tanaka, T. Yoshizawa, Y. Nishizawa, Y. Mori, T. Niidome, and S. Shoji Differential nociceptive responses in mice lacking the alpha(1B) subunit of N-type Ca(2 +) channels NeuroReport 12 2001 2423 2427
96. D.A. Scott, C.E. Wright, and J.A. Angus Actions of intrathecal omega-conotoxins CVID GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat Eur. J. Pharmacol. 451 2002 279 286
97. M. Wang, J. Offord, D.L. Oxender, and T.Z. Su Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding Biochem. J. 342 Pt 2 1999 313 320
98. M.L. LaCroix-Fralish, J.S. Austin, F.Y. Zheng, D.J. Levitin, and J.S. Mogil Patterns of pain: meta-analysis of microarray studies of pain Pain 152 2011 1888 1898
99. M.A. Takasu, M.B. Dalva, R.E. Zigmond, and M.E. Greenberg Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors Science 295 2002 491 495
100. L.J. Wu, and M. Zhuo Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain Neurotherapeutics 6 2009 693 702
101. E.B. Pasquale Eph-ephrin promiscuity is now crystal clear Nat. Neurosci. 7 2004 417 418
102. J.P. Himanen, K.R. Rajashankar, M. Lackmann, C.A. Cowan, M. Henkemeyer, and D.B. Nikolov Crystal structure of an Eph receptor-ephrin complex Nature 414 2001 933 938
103. A. Ghosh Neurobiology. Learning more about NMDA receptor regulation Science 295 2002 449 451
104. M.J. Nolt, Y. Lin, M. Hruska, J. Murphy, S.I. Sheffler-Colins, M.S. Kayser, J. Passer, M.V. Bennett, R.S. Zukin, and M.B. Dalva EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner J. Neurosci. 31 2011 5353 5364
105. E.B. Pasquale Eph receptor signalling casts a wide net on cell behaviour Nat. Rev. Mol. Cell Biol. 6 2005 462 475
106. C.G. Parsons NMDA receptors as targets for drug action in neuropathic pain Eur. J. Pharmacol. 429 2001 71 78
107. J. Scholz, and C.J. Woolf The neuropathic pain triad: neurons, immune cells and glia Nat. Neurosci. 10 2007 1361 1368
108. S.T. Meller, C. Dykstra, D. Grzybycki, S. Murphy, and G.F. Gebhart The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat Neuropharmacology 33 1994 1471 1478
109. L.R. Watkins, E.D. Milligan, and S.F. Maier Glial activation: a driving force for pathological pain Trends Neurosci. 24 2001 450 455
110. E.D. Milligan, C. Twining, M. Chacur, J. Biedenkapp, K. O'Connor, S. Poole, K. Tracey, D. Martin, S.F. Maier, and L.R. Watkins Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats J. Neurosci. 23 2003 1026 1040
111. R.R. Ji, and M.R. Suter p38 MAPK, microglial signaling, and neuropathic pain Mol. Pain 3 2007 33
112. Y.-J. Gao, and R.-R. Ji Targeting astrocyte signaling for chronic pain Neurotherapeutics 7 2010 482 493
113. J. Zhang, X.Q. Shi, S. Echeverry, J.S. Mogil, Y. De Koninck, and S. Rivest Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain J. Neurosci. 27 2007 12396 12406
114. C. Abbadie Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Proc. Natl. Acad. Sci. 100 2003 7947 7952
115. C.I. Lin, C.-N. Chen, J.H. Chen, and H. Lee Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism J. Cell. Biochem. 99 2006 1216 1232
116. R. Fujita, Y. Ma, and H. Ueda Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia J. Neurochem. 107 2008 152 160
117. E. Bernhart, M. Kollroser, G. Rechberger, H. Reicher, A. Heinemann, P. Schratl, S. Hallstrom, A. Wintersperger, C. Nusshold, T. DeVaney, K. Zorn-Pauly, R. Malli, W. Graier, E. Malle, and W. Sattler Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture Proteomics 10 2010 141 158
118. T. Moller Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells J. Biol. Chem. 276 2001 25946 25952
119. A. Ledeboer, E.M. Sloane, E.D. Milligan, M.G. Frank, J.H. Mahony, S.F. Maier, and L.R. Watkins Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation Pain 115 2005 71 83
120. V. Raghavendra, F. Tanga, and J.A. DeLeo Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy J. Pharmacol. Exp. Ther. 306 2003 624 630
121. H. Ueda Lysophosphatidic acid as the initiator of neuropathic pain Biol. Pharm. Bull. 34 2011 1154 1158
122. L. Ma, H. Uchida, J. Nagai, M. Inoue, J. Chun, J. Aoki, and H. Ueda Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain Mol. Pain 5 2009 64
123. M. Matsumoto, W. Xie, L. Ma, and H. Ueda Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury Mol Pain 4 2008 25
124. L. Ma, M. Matsumoto, W. Xie, M. Inoue, and H. Ueda Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist J. Neurochem. 109 2009 603 610
125. 2 + channels that is required for T cell activation J. Biol. Chem. 283 2008 12512 12519
126. K. Yashpal, G.M. Pitcher, A. Parent, R. Quirion, and T.J. Coderre Noxious thermal and chemical stimulation induce increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C J. Neurosci. 15 1995 3263 3272
127. J. Balsinde, and E.A. Dennis Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages J. Biol. Chem. 271 1996 6758 6765
128. E.A. Dennis The growing phospholipase A2 superfamily of signal transduction enzymes Trends Biochem. Sci. 22 1997 1 2
129. M. Tanaka, Y. Kishi, Y. Takanezawa, Y. Kakehi, J. Aoki, and H. Arai Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma FEBS Lett. 571 2004 197 204
130. K. Sato, E. Malchinkhuu, T. Muraki, K. Ishikawa, K. Hayashi, M. Tosaka, A. Mochiduki, K. Inoue, H. Tomura, C. Mogi, H. Nochi, K. Tamoto, and F. Okajima Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources J. Neurochem. 92 2005 904 914
131. M. Inoue, L. Ma, J. Aoki, J. Chun, and H. Ueda Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain Mol. Pain 4 2008 6
132. W.A. Barton, B.P. Liu, D. Tzvetkova, P.D. Jeffrey, A.E. Fournier, D. Sah, R. Cate, S.M. Strittmatter, and D.B. Nikolov Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins EMBO J. 22 2003 3291 3302